NCT07234331 A Multicentre Study of Wastewater and Antibiotic Resistance in Care Homes.
| NCT ID | NCT07234331 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nantes University Hospital |
| Condition | Antimicrobial Resistance |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,600 participants |
| Start Date | 2026-03-16 |
| Primary Completion | 2027-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,600 participants in total. It began in 2026-03-16 with a primary completion date of 2027-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to model the relationship between the prevalence of ESBL-E and CPE carriage among nursing home residents and their respective concentrations in wastewater discharged from the facility.
Eligibility Criteria
Inclusion Criteria: * Residents present on the day of sampling (D0 or D+1) in a facility selected during randomization, without criteria regarding length of stay in the facility, and whose health status on the day of the survey permits it; * Residents who, based on clinical criteria (including an MMSE greater than or equal to 20), are deemed by the nursing home team to be able to understand the issues of the study and to express an informed non-opposition; OR Residents who the nursing home team considers unable to express an informed non-objection but who have a legal representative, a trusted person, or a loved one capable of understanding the information and expressing an informed non-objection. Residents may be included regardless of the presence of infection, diarrheal stools, antibiotic use or any other treatment, or health status. Participants in this study may participate in other research projects concurrently. Exclusion Criteria: Health and medico-social facilities not considered nursing homes (e.g., FAM, MAS, etc.); * Residents whose health status is incompatible with performing the procedure on the day of the survey (e.g., end-of-life with comfort care); * Residents with a Mini Mental State Examination (MMSE) score of less than or equal to 20, or without an MMSE score but who, according to nursing home professionals, are unable to provide an informed non-objection and who do not have a legal representative, trusted person, or relative capable of receiving information and providing an informed non-objection; * Residents, regardless of their MMSE score, who refuse to have the sample taken on the day of the survey even if their legal repre
Frequently Asked Questions
Who can join the NCT07234331 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Antimicrobial Resistance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07234331 currently recruiting?
Yes, NCT07234331 is actively recruiting participants. Visit ClinicalTrials.gov or contact Nantes University Hospital to inquire about joining.
Where is the NCT07234331 trial being conducted?
This trial is being conducted at Angers, France, Nantes, France.
Who is sponsoring the NCT07234331 clinical trial?
NCT07234331 is sponsored by Nantes University Hospital. The trial plans to enroll 1,600 participants.